| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 256,367 | 260,604 | 258,475 | 279,558 | | Cost of Revenue | 191,410 | 194,675 | 193,593 | 205,426 | | | Gross Profit | 64,957 | 65,929 | 64,882 | 74,132 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 56,417 | 57,004 | 56,458 | 64,268 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,506 | 1,457 | 1,408 | 1,451 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,034 | 7,468 | 7,016 | 8,413 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (339) | 500 | 1,267 | (80) | | Earnings Before Interest And Taxes | 6,695 | 7,968 | 8,283 | 8,184 | | Interest Expense | 1,735 | 1,053 | 1,570 | 1,683 | | Income Before Tax | 4,960 | 6,915 | 6,713 | 6,501 | | Income Tax Expense | 1,401 | 2,206 | 2,416 | 527 | | Minority Interest | (139) |
-
|
-
| (149) | | | | Net Income From Continuing Ops | 3,420 | 4,709 | 4,297 | 5,974 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,420 | 4,709 | 4,297 | 5,974 | | Preferred Stock And Other Adjustments | 85 | (53) | (32) |
-
| | | Net Income Applicable To Common Shares | $3,505 | $4,656 | $4,265 | $5,974 |
|
1.52% Nasdaq 
Income Statement
